These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8965839)

  • 1. Rapid death of injected myoblasts in myoblast transfer therapy.
    Fan Y; Maley M; Beilharz M; Grounds M
    Muscle Nerve; 1996 Jul; 19(7):853-60. PubMed ID: 8965839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells.
    Hodgetts SI; Beilharz MW; Scalzo AA; Grounds MD
    Cell Transplant; 2000; 9(4):489-502. PubMed ID: 11038066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts.
    Hodgetts SI; Grounds MD
    J Cell Sci; 2003 Oct; 116(Pt 20):4131-46. PubMed ID: 12972504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice.
    Lee-Pullen TF; Bennett AL; Beilharz MW; Grounds MD; Sammels LM
    Transplantation; 2004 Oct; 78(8):1172-6. PubMed ID: 15502715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts.
    Fan Y; Beilharz MW; Grounds MD
    Cell Transplant; 1996; 5(3):421-9. PubMed ID: 8727011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation.
    Hodgetts SI; Spencer MJ; Grounds MD
    Transplantation; 2003 Mar; 75(6):863-71. PubMed ID: 12660516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
    Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
    Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
    Brussee V; Merly F; Tardif F; Tremblay JP
    Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer into skeletal muscles by isogenic myoblasts.
    Huard J; Acsadi G; Jani A; Massie B; Karpati G
    Hum Gene Ther; 1994 Aug; 5(8):949-58. PubMed ID: 7948144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of myoblast culture and myoblast transfer therapy in dystrophic mice].
    Jong HJ; Chen SS; Chuang YH; Chen TJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):398-408. PubMed ID: 7650779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy.
    Sammels LM; Bosio E; Fragall CT; Grounds MD; van Rooijen N; Beilharz MW
    Transplantation; 2004 Jun; 77(12):1790-7. PubMed ID: 15223893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle.
    Smythe GM; Fan Y; Grounds MD
    Muscle Nerve; 2000 Apr; 23(4):560-74. PubMed ID: 10716768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle].
    Takemitsu M; Arahata K; Nonaka I
    Rinsho Shinkeigaku; 1990 Oct; 30(10):1066-72. PubMed ID: 2279357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts.
    Chen M; Li HJ; Fang Q; Goodwin TG; Florendo JA; Law PK
    Cell Transplant; 1992; 1(1):17-22. PubMed ID: 1344288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
    Mueller GM; O'Day T; Watchko JF; Ontell M
    Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
    Pellegrini KL; Beilharz MW
    Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.